Recombinant multi-epitope antigen ChimEBV-EA for Epstein-barr virus (EBV)

Epstein-barr virus (EBV)

The recombinant chimeric early antigen ChimEBV-EA for Epstein-Barr Virus (EBV) has been prepared as a recombinant multi-epitope antigen fused to a his-tag and trxA at the N-terminal

Recombinant antigen for the diagnosis of Epstein-Barr virus infection (EBV), a human infectious disease.

More information about chimeras (multi-epitope proteins).

or
Name
ChimEBV-EA
Description
Multi-epitope recombinant chimeric early antigen for Epstein-Barr Virus (EBV)
Purity
> 95% by observation on SDS-PAGE electrophoresis
Cat number
SKU Source Applications In-house validation Details
RAG0082 (chimera) New E. coli WB, DB, IE, DE, CLIA, LF ELISA Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk
* under availability, for liquid format
Related proteins
ChimEBV-VCA EBNA1 p138 p18 p23 p54 ZEBRA

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Recombinant antigens for infectious diseases

How to reconsitute lyophizated vials

Recombinant antigens for the diagnosis of Epstein-Barr Virus (EBV)